Pen injectors for insulin

1992 ◽  
Vol 30 (1) ◽  
pp. 3-4

Over the last 10 years, intensified insulin regimens have been developed in the hope that improved glycaemic control will help prevent diabetic complications. The regimens involve either continuous subcutaneous insulin infusion (CSII) via a motorised pump1 or, more commonly, multiple subcutaneous injections. The multiple injection regimens usually consist of a short-acting insulin before meals with long or medium-acting insulin at bedtime (‘basal-bolus’ regimens). Pen-like injectors, which simplify the transport and injection of insulin, were developed to make these multiple dose regimens more acceptable and convenient. They are also increasingly being used with twice daily, mixed insulin regimens.

2016 ◽  
Vol 11 (1) ◽  
pp. 165-171 ◽  
Author(s):  
Ralph Ziegler ◽  
Guido Freckmann ◽  
Lutz Heinemann

Giving a bolus is one major part in multiple dose insulin therapy (MDI) along with basal insulin substitution. To adjust the bolus optimally, different factors like carbohydrate content and composition of the meal, correction factors, and timing have to be considered. Advances in technologies like bolus advisors can assist the patients but still there a several open questions and technical challenges regarding boluses. This commentary provides an opportunity to address several of the above-mentioned factors influencing the result of bolusing. It shall draw attention to those factors and address the current opportunities, for example, continuous subcutaneous insulin infusion (CSII), as well as the need for further studies which can help to improve diabetes insulin therapy by means of the correct use of boluses.


Sign in / Sign up

Export Citation Format

Share Document